Abstract
Background and AimsThe development of refractory ascites in liver cirrhosis portends a poor prognosis with a 2-year survival of 30%.1Model for End-stage Liver Disease (MELD) was initially created to predict...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
